Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay

Katleen De Preter,Frank Speleman,Valérie Combaret,John Lunec,Geneviève Laureys,Bert H J Eussen,Nadine Francotte,Julian Board,Andy D J Pearson,Anne De Paepe,Nadine Van Roy,Jo Vandesompele
DOI: https://doi.org/10.1038/modpathol.3880508
IF: 8.209
2002-02-01
Modern Pathology
Abstract:Amplification of the proto-oncogene MYCN is a strong adverse prognostic factor in neuroblastoma patients in all tumor stages. The status of the MYCN gene has become an important factor in clinical decision making and therapy stratification. Consequently, fast and accurate assessment of MYCN gene copy number is of the utmost importance and the use of two independent methods to determine MYCN status is recommended. For these reasons we have developed and evaluated a real-time quantitative PCR (Q-PCR) assay as an alternative for time-consuming Southern blot analysis (SB), and as a second independent technique in parallel with fluorescence in situ hybridization (FISH) analysis. Advantages of Q-PCR are a large dynamic range of quantification, no requirement for post-PCR sample handling and the need for very small amounts of starting material. The accuracy of the assay was illustrated by measurement of MYCN single gene copy changes in DNA samples of two patients with 2p deletion and duplication, respectively. Two different detection chemistries i.e., a sequence specific TaqMan probe and a generic DNA binding dye SYBR Green I were evaluated and shown to yield similar results. Also, two different calculation methods for copy number determination were used i.e., the kinetic method and the comparative C(T) method, and shown to be equivalent. In total, 175 neuroblastoma samples with known MYCN status, as determined by FISH and/or SB, were examined. Q-PCR data were highly concordant with FISH and SB data. In addition to MYCN copy number evaluation, DDX1 and NAG gene copy numbers were determined using a similar Q-PCR strategy. Survival analysis pointed out that DDX1 and/or NAG amplification has no additional adverse effect on prognosis.
pathology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to develop and evaluate a real - time quantitative PCR (Q - PCR) detection method for rapidly and accurately determining the copy numbers of the MYCN, DDX1 and NAG genes in neuroblastoma (NB) samples. Specifically, the study aims to: 1. **Replace time - consuming traditional methods**: Although traditional Southern blot analysis is accurate, it is time - consuming and requires a large amount of fresh or frozen sample material, while real - time quantitative PCR can reduce the required sample amount and increase the detection speed. 2. **Provide an independent verification means**: As a second independent technique other than fluorescence in situ hybridization (FISH) analysis, ensure the reliability of the MYCN gene copy number detection results. 3. **Achieve high - sensitivity and wide - dynamic - range quantification**: By optimizing experimental conditions, such as using TaqMan probes and SYBR Green I dye, and comparing two calculation methods (the standard curve method and the comparative C<sub>T</sub> method), to ensure the sensitivity and accuracy of the detection. 4. **Evaluate the amplification of other related genes and their impact on prognosis**: In addition to MYCN, the copy numbers of DDX1 and NAG genes were also determined, and it was explored whether they would have an additional adverse impact on the patient's survival time. ### Main research contents - **Selection and evaluation of reference genes**: Two genes, BCMA and SDC4, located in regions of the chromosome with fewer genetic abnormalities were selected as internal reference genes, ensuring the accuracy of data normalization. - **Comparison of different chemical detection methods**: TaqMan probes and SYBR Green I dye were used respectively to determine the MYCN copy number, and the results showed a high degree of consistency (Spearman correlation coefficient was 0.963, p < 0.01). - **Verification of the accuracy of the detection method**: By detecting patient samples with known 2p segment deletions or duplications, it was proved that this method can detect changes in the copy number of a single gene. - **Comparison with FISH and Southern blot results**: In 175 samples, 98.9% of the results were consistent with FISH or Southern blot analysis, further validating the effectiveness of the Q - PCR method. - **Determination of the minimum DNA requirement and the influence of the tumor cell proportion**: Even with only 0.1 ng DNA or a 20% tumor cell proportion, the amplification state of MYCN can be successfully detected. - **Determination of the DDX1 and NAG gene copy numbers**: It was found that DDX1 co - amplification exists in about half of the MYCN - amplified samples, and NAG co - amplification exists in one - third, but the amplification of these genes did not significantly affect the patient's survival rate. In summary, the core objective of this paper is to establish an efficient, accurate and easy - to - operate Q - PCR platform in order to better assist the clinical diagnosis and treatment decision - making of neuroblastoma.